Liberum Capital Reaffirms Hold Rating for Spire Healthcare Group PLC (SPI)
Liberum Capital reiterated their hold rating on shares of Spire Healthcare Group PLC (LON:SPI) in a report released on Thursday morning. They currently have a GBX 350 ($4.52) target price on the stock.
A number of other equities research analysts have also recently commented on the company. Numis Securities Ltd reiterated an add rating and set a GBX 375 ($4.84) target price on shares of Spire Healthcare Group PLC in a research note on Wednesday, July 26th. Credit Suisse Group reiterated an underperform rating on shares of Spire Healthcare Group PLC in a research note on Friday, July 21st. Berenberg Bank lifted their target price on Spire Healthcare Group PLC from GBX 360 ($4.65) to GBX 390 ($5.04) and gave the stock a buy rating in a research note on Wednesday, June 21st. Finally, Jefferies Group LLC lifted their target price on Spire Healthcare Group PLC from GBX 305 ($3.94) to GBX 350 ($4.52) and gave the stock a hold rating in a research note on Thursday, June 1st. One analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company. The company currently has an average rating of Hold and a consensus price target of GBX 347 ($4.48).
Spire Healthcare Group PLC (SPI) opened at 260.20 on Thursday. The firm’s market capitalization is GBX 1.04 billion. The firm has a 50 day moving average of GBX 327.79 and a 200 day moving average of GBX 332.90. Spire Healthcare Group PLC has a 12-month low of GBX 228.48 and a 12-month high of GBX 411.00.
Spire Healthcare Group PLC (LON:SPI) last released its earnings results on Thursday, September 14th. The company reported GBX 8.70 ($0.11) EPS for the quarter, topping the Zacks’ consensus estimate of GBX 8.60 ($0.11) by GBX 0.10 ($0.00). The company had revenue of £481 million for the quarter. Spire Healthcare Group PLC had a return on equity of 3.47% and a net margin of 3.92%. On average, analysts forecast that Spire Healthcare Group PLC will post $18.48 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Liberum Capital Reaffirms Hold Rating for Spire Healthcare Group PLC (SPI)” was first posted by Daily Political and is owned by of Daily Political. If you are reading this news story on another domain, it was stolen and reposted in violation of US & international trademark & copyright law. The original version of this news story can be accessed at https://www.dailypolitical.com/2017/09/17/liberum-capital-reaffirms-hold-rating-for-spire-healthcare-group-plc-spi.html.
Spire Healthcare Group PLC Company Profile
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.